Target N. V. Biotech, 10% Owner at Radius Health, Inc. (RDUS), bought 398,058 shares at $11.33 ($4.5M) on 2020-09-11, disclosed to the SEC on 2020-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.33 | 199,029 | $2.3M | 50.0% |
| 2 | $11.33 | 199,029 | $2.3M | 50.0% |
| Total | $11.33 avg | 398,058 | $4.5M | 100% |
| Filing → |
| MGNX | BUY | 2023-01-23 | $795K | — | Filing → |
| MGNX | BUY | 2022-11-25 | $1.8M | — | Filing → |
| MTEM | BUY | 2022-05-18 | $236K | — | Filing → |